Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of April 12, 2026

By DrugPatentWatch / April 17, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

JATENZO (testosterone undecanoate)

Tolmar Patent: 11,179,402 Expiration: Apr 14, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

The Patent Playbook for Pharma: Protect Your Drug.…
Effective Drug Patent Prosecution Strategies:…
Build a Live Drug Patent LOE Dashboard Your…
Addressing the Challenges of Pharmaceutical…
Mine the Orange Book: How FDA Drug Patent Data…
Unlocking the Potential of Abandoned and Expired…
Beyond the Prescription Pad: Why Patent Intelligence…
The Patent Cliff Playbook: Transforming Drug Patent…
Mastering the New Rules of Small Molecule-Biologic…
How CDMOs Can Use Patent Data to Win More…
Marketing Your Patented Drug Effectively: Strategies…
Optimizing Generic Drug Manufacturing: Strategies…
The High-Stakes Game of Pharma IP: Why Benchmarking…
Predict The Patent Cliff: The Patent Cliff Is…
Patent Expiration Dates: The Calendar Every…
Competitive Intelligence in Excipients: How to Know…
How Financial Analysts Use Drug Patent Expiry Data…
Using Drug Patents to Block Competitors: The Tactics…
How to Search Drug Patents: The Competitive…
How to Evaluate CDMO Performance: The Definitive…
Managing Drug Patent Portfolios Effectively: A…
A Pharma Exec's Guide to Preliminary…
How to Spot Formulation Switch Opportunities Before…
The Global Generic Drug Market: Trends,…

Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry

Slash drug discovery timelines with GPT-Rosalind

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of January 18, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Slash drug discovery timelines with GPT-Rosalind
Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

Popular Posts

CHEMOCENTRYX, INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Patent Expiration Dates: The Calendar Every Pharmaceutical Investor Watches
Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
Brazilian Pharmaceuticals 2026: The Innovation & Patent Cliff Frontier
China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
The Top 10 Longest-Running Drug Patents
Drug Patent Expiration: The Complete Strategic Guide to Loss of Exclusivity, Lifecycle Management, and the $400 Billion Cliff
The Ultimate Guide to CDMO Pricing
What are the top Biopharmaceutical Business Intelligence Services?

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on April 17, 2026 by DrugPatentWatch